Experimental techniques for testing the sensitivity of bladder tumours to antineoplastic drugs.
D000287:Administration, Topical; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology; D002467:Cell Nucleus; D006224:Cricetinae; D003601:Cytotoxicity Tests, Immunologic; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003630:Daunorubicin / Q000627:therapeutic use; D003703:Demecolcine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004351:Drug Resistance; D005453:Fluorescence; D006027:Glycosides / Q000627:therapeutic use; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use; D008856:Microscopy, Fluorescence; D009368:Neoplasm Transplantation; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D011034:Podophyllotoxin / Q000627:therapeutic use; D014176:Protein Biosynthesis; D013876:Thiophenes / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D014183:Transplantation, Heterologous; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D006027:Glycosides; D013876:Thiophenes; D004317:Doxorubicin; D013852:Thiotepa; D010088:Oxidoreductases; D011034:Podophyllotoxin; D008558:Melphalan; D003703:Demecolcine; D003630:Daunorubicin